Detalles de la búsqueda
1.
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.
N Engl J Med
; 380(24): 2317-2326, 2019 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31189035
2.
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
Gynecol Oncol
; 164(2): 428-436, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34903380
3.
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 164(2): 398-405, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34857397
4.
Sera Protein Signatures of Endometrial Cancer Lymph Node Metastases.
Int J Mol Sci
; 23(6)2022 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35328698
5.
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study.
Gynecol Oncol
; 161(1): 113-121, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33541735
6.
Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
Cancer
; 126(22): 4948-4956, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32910478
7.
An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275.
Gynecol Oncol
; 158(2): 354-360, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32460997
8.
GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 153(2): 335-342, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30827726
9.
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 151(3): 422-427, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30309721
10.
BMI1, a new target of CK2α.
Mol Cancer
; 16(1): 56, 2017 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28270146
11.
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.
Radiology
; 283(2): 450-459, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28051912
12.
Effectiveness of cyanoacrylate microbial sealant in the reduction of surgical site infection in gynecologic oncology procedures: A phase III single institution prospective randomized trial.
Gynecol Oncol
; 144(1): 193-199, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27836205
13.
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 146(3): 477-483, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28756871
14.
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229N.
Gynecol Oncol
; 138(1): 24-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25888978
15.
A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.
Gynecol Oncol
; 133(3): 537-41, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24594074
16.
Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.
Cancer Lett
; 578: 216437, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37838282
17.
Tubal ligation frequency in Oklahoma women with cervical cancer.
Gynecol Oncol
; 127(2): 278-82, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22858904
18.
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.
J Clin Oncol
; 40(28): 3289-3300, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658479
19.
Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial.
J Clin Oncol
; 40(19): 2138-2147, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290101
20.
Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.
Cancers (Basel)
; 14(17)2022 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077609